IHI call 13

IHI call 13 is a two-stage call with topics on accelerating healthcare innovation through networks, reducing animal use in drug safety studies, and decoding the immuno-science of diseases affected by ageing and the immune system.

Key call information

Topics

Important information on eligibility for funding

Legal entities based in all countries associated to Horizon Europe, including Canada, Switzerland, the UK, and South Korea, will be eligible to receive funding under this call, in line with the normal rules.

Find out more about the topics

For full details of the topics, including the budget breakdown, read the call text. All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page.  We advise you to read these documents, in particular the guide for applicants, carefully. The FAQ document now also includes specific questions on this topic and applicants should read these carefully.

Key dates and deadlines

  • Draft topic texts published: 22 April, updated 09 June
  • Call launch: 2 July 2026
  • Short proposal submission deadline: 08 October 2026 at 17:00 Brussels time
  • Full proposal submission deadline: 21 April 2027 at 17:00 Brussels time

Other useful information

  • Call ID: HORIZON-JU-IHI-2026-13-two-stage | Action type: RIA - Research and Innovation Actions | Call type: Two-stage

 

Indicative budget
  • The maximum financial contribution from IHI JU for these topics is: EUR 53.2 million
  • Industry / contributing partner contributions:
    EUR 31.6 million
Find partners
  • Get advice on finding partners.

 

How to apply

Proposals must be submitted via the electronic submission system of the Funding and Tenders Portal. To start submitting your proposal, simply click on the relevant topic above - this will take you directly to that topic's page on the portal. Once there, scroll down and click on 'Start submission'.

To submit a proposal via the electronic submission system, you will need to have an EU Login account and ensure that your organisation is registered as a beneficiary.

Additional information and support

Questions?